Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabetes
Open Access
- 9 March 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Abstract
Therapeutic approaches to combat type 1 diabetes (T1D) include donor pancreas transplantation, exogenous insulin administration and immunosuppressive therapies. However, these clinical applications are limited due to insufficient tissue compatible donors, side effects of exogenous insulin administration and/or increased onset of opportunistic infections attributable to induced global immunosuppression. An alternative approach to alleviate disease states is to utilize insulin-producing pancreatic islets seeded in a bioscaffold for implantation into diabetic recipients. The present studies now report that a newly developed cationic polymer biomaterial serves as an efficient bioscaffold for delivery of donor syngeneic pancreatic islet cells to reverse hyperglycemia in murine streptozotocin induced- or non-obese diabetic mouse models of T1D. Intraperitoneal implantation of pancreatic islets seeded within the copolymer bioscaffold supports long-term cell viability, response to extracellular signaling cues and ability to produce soluble factors into the microenvironment. Elevated insulin levels were measured in recipient diabetic mice upon implantation of the islet-seeded biomaterial coupled with reduced blood glucose levels, collectively resulting in increased survival and stabilization of metabolic indices. Importantly, the implanted islet-seeded biomaterial assembled into a solid organoid substructure that reorganized the extracellular matrix compartment and recruited endothelial progenitors for neovascularization. This allowed survival of the graft long-termin vivoand access to the blood for monitoring glucose levels. These results highlight the novelty, simplicity and effectiveness of this biomaterial for tissue regeneration andin vivorestoration of organ functions.Keywords
This publication has 38 references indexed in Scilit:
- Oxygenation of the Intraportally Transplanted Pancreatic IsletJournal of Diabetes Research, 2016
- Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent miceNature Medicine, 2016
- A New Home for Pancreatic Islet Transplants: The Bone MarrowDiabetes, 2013
- The Use of Biomaterials in Islet TransplantationCurrent Diabetes Reports, 2011
- Loss of Resistin Improves Glucose Homeostasis in Leptin DeficiencyDiabetes, 2006
- Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistanceFrontiers in Neuroendocrinology, 2003
- The design of polymer microcarrier surfaces for enhanced cell growthBiomaterials, 2003
- Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 DiabetesUpsala Journal of Medical Sciences, 2000
- Macrophages and angiogenesisJournal of Leukocyte Biology, 1994
- Studies of streptozotocin-induced insulitis and diabetes.Proceedings of the National Academy of Sciences, 1977